candesartan cilexetil has been researched along with Liver Diseases in 1 studies
candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects
Liver Diseases: Pathological processes of the LIVER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Candesartan cilexetil was found to have a good safety profile and to be well tolerated by patients with hepatic or renal impairment." | 1.30 | Pharmacokinetics of candesartan cilexetil in patients with renal or hepatic impairment. ( de Zeeuw, D; Kirch, W; Remuzzi, G, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Zeeuw, D | 1 |
| Remuzzi, G | 1 |
| Kirch, W | 1 |
1 other study available for candesartan cilexetil and Liver Diseases
| Article | Year |
|---|---|
Pharmacokinetics of candesartan cilexetil in patients with renal or hepatic impairment.
Topics: Adolescent; Adult; Aged; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; | 1997 |